announced today that it entered into an agreement with the Targeted Alpha Therapy Group (TAT Group) at the University of Gothenburg in Sweden to collaborate on the research and development of farletuzumab as an alpha therapy vector being studied for radioimmunotherapy
in ovarian cancer.
Washington, Dec 04 ( ANI ): Researchers have used radioimmunotherapy
(RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection.
Dr Ekaterina Dadachova and colleagues from Albert Einstein College of Medicine of the Yeshiva University in the US found that radioimmunotherapy
(RIT) was successful in destroying the HIV-infected cells without affecting or causing any harm to the healthy cells.
Extremely targeted cancer- treatment - In 2011, Areva Med, working with researchers from the University of Alabama, got the green light from the US Food and Drug Administration to start a phase one clinical trial with Pb 212, using radioimmunotherapy
It contains more than 2,000 questions and answers, updated chapters, and a new chapter of radionuclide therapy with information on radioimmunotherapy
of lymphoma and Y-90 SIRT of hepatitic malignancies.
The inherent radiosensitivity of most NHLs and the availability of a good antigenic target (CD20) and corresponding monoclonal antibody provided the rationale for the development of radioimmunotherapy
(RIT) for the treatment of B-cell NHL .
At the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), two studies were presented investigating the potential utility of Zevalin (Ibritumomab Tiuxetan) radioimmunotherapy
as replacement for external beam radiations or supplement to high-dose chemotherapy in the treatment of non-Hodgkin's lymphoma (NHL).
The seven articles discuss a range of topics: anti-angiogenic strategies in hepatocellular carcinoma, rheumatoid arthritis, metronomic chemotherapy, combined radioimmunotherapy
and anti-angiogenic therapy to treat cancer, quinines as anti-angiogenic agents, neovascular ocular disease, and diabetic retinopathy.
With the data showing that radioactive antibodies could selectively target and image diseases that express the specific antigens, we and other researchers focused on applying this technology to radioimmunotherapy
(RAIT) of cancer.
Tokyo, Japan, July 10, 2006 - (JCN) - Nihon Schering announced on June 4 that it signed a joint business contract with Daiichi Radioisotope Laboratories (DRL) regarding Zevalin, a radioimmunotherapy
agent used in the treatment of non-Hodgkin's lymphoma.
These results are exciting and further follow-up is needed to determine the long-term efficacy of combining frontline radioimmunotherapy
with antibody-based maintenance.
When FL has progressed after an initial treatment regimen, radioimmunotherapy
now may be considered as a second-line option.